Tuesday, March 17, 2026

South Korea Stays in Washington to Assess Fallout From U.S. Tariffs on AI Semiconductors

Yeo Han Koo extends his stay in the U.S. to assess the impact of new tariffs on AI semiconductors, emphasizing careful monitoring.

Wall Street Woes: NVIDIA and Tech Stocks Slide Amid Recession Fears

As Nvidia's stock fell nearly 2%, the Philadelphia Semiconductor Index also experienced a more than 1% decline.

Unmanned Aerial Vehicles in Focus: North Korea’s Claims and the Ongoing Investigation Explained

South Korea's Unification Ministry is monitoring North Korea's response to drone incursions, with investigations ongoing into the incident.

Tag: drug

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

New Obesity Pill Could End Wegovy’s Reign, Offering Faster and Safer Results

Ildong's ID110521156 shows promise as an affordable GLP-1 obesity drug with fewer side effects, aiming to transform the treatment landscape.

This New Drug Could Stop Kidney Failure After Heart Surgery

Bilix receives MFDS approval for Phase 2a trial of Brixelle, targeting acute kidney injury in cardiac surgery patients.

No Batteries Needed: These Microscopic Robots Run on Urea

KAIST develops a self-propelled cell robot powered by urea, enabling autonomous movement for targeted transport and environmental modulation.

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Safe Medication Use During Pregnancy: What You Need to Know

Expectant mothers should consult healthcare providers about medication use during pregnancy to ensure safety for both mother and baby.

New Hope for Alcohol-Related Liver Disease: GLP-1 Drugs Show Promise

Research shows that GLP-1 receptor agonists, like Wegovy, may help combat alcohol-related liver disease, reducing liver cancer risk.

How AI is Changing the Game for Drug Makers!

This joint initiative aims to reduce the costs and time associated with new drug development using AI models based on federated learning.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.